Establishment Labs Reports Strong Q1 Results, Raises Full-Year Revenue Guidance

summarizeSummary

Establishment Labs reported strong Q1 2026 financial results, including significant revenue growth and positive Adjusted EBITDA, leading to an upward revision of its full-year revenue guidance and a projected free cash flow positive second half.

check_boxKey Events

• Strong Q1 2026 Financial Performance

  Reported revenue of $59.9 million, a 44.7% increase from Q1 2025, with gross margin improving to 70.7% from 67.2% in the prior-year period. Loss from operations significantly reduced to $6.5 million from $16.9 million.

• Achieved Positive Adjusted EBITDA

  Reported Adjusted EBITDA income of $1.2 million for Q1 2026, a substantial improvement from a $12.1 million loss in the year-ago period, marking the third consecutive quarter of positive Adjusted EBITDA.

• Raised Full-Year 2026 Guidance

  Increased full-year revenue guidance to a range of $266.5 million to $268.5 million, up from the previous range of $264 million to $266 million. Guidance for the minimally invasive business was also raised to exceed $35 million.

• Path to Free Cash Flow Positive

  The company expects to be free cash flow positive in the second half of 2026, further enhancing its financial stability.

auto_awesomeAnalysis

Establishment Labs Holdings Inc. reported robust first-quarter results, demonstrating significant operational leverage and strong growth. The company achieved a 44.7% year-over-year revenue increase and notably shifted to a positive Adjusted EBITDA of $1.2 million, marking its third consecutive quarter of positive Adjusted EBITDA. This strong performance has led management to raise its full-year 2026 revenue guidance and increase expectations for its minimally invasive business. The improved financial outlook, coupled with the recently secured $300 million credit facility on April 30, 2026, significantly enhances the company's financial flexibility and provides a clear path to becoming free cash flow positive in the second half of the year. This filing indicates a positive trajectory for the company's financial health and growth strategy.